Simplifying Global Compliance
HeartWare Touts Promising Pipeline During Third-Quarter Call
HeartWare International plans to present data from the Endurance destination therapy trial of its ventricular assist device in early 2015 and could file a PMA sometime before that, CEO Doug Godshall said on a Thursday third-quarter earnings call.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing